| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 8e-05 |